Form EFFECT Compass Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 7, 2026 10:00 A.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Compass Therapeutics (CMPX) PT Lowered to $12 at H.C. Wainwright
- AI Sports: Quantum Kill Switch Defuses Public 'Skynet' Threats (Veterans First for America)
- CG Advisory Services Launched CG Flagship Equity ETF
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share